Latest / Making it in Manufacturing
Inside Mabion’s Growth Strategy | CEO Gregor Kawaletz on Biosimilars & Biologics
What does it take to step into a publicly listed CDMO and immediately reposition it for growth in a shifting global market? At Mabion, it starts with people, scientific excellence and a clear commercial vision.
This week on Making It In Manufacturing, Thomas McMann sat down with Gregor Kawaletz, CEO of Mabion, bringing over 20 years of experience in the CDMO space spanning leadership roles across NextPharma, Catalent and Recipharm. Now in the first month as CEO, Gregor shares why this move was about broader impact and how the organisation will be steered into its next phase.
In this episode…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.